Liraglutide reverses pronounced insulin-associated weight gain, improves glycaemic control and decreases insulin dose in patients with type 2 diabetes: a 26 week, randomised clinical trial (ELEGANT)
Crossref DOI link: https://doi.org/10.1007/s00125-014-3302-0
Published Online: 2014-06-20
Published Print: 2014-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
de Wit, Helena M.
Vervoort, Gerald M. M.
Jansen, Henry J.
de Grauw, Wim J. C.
de Galan, Bastiaan E.
Tack, Cees J.
Text and Data Mining valid from 2014-06-20